References
- Assouly P, Reygagne P. Lichen planopilaris: update on diagnosis and treatment. Semin Cutan Med Surg. 2009;28:3–10.
- Cevasco NC, Bergfeld WF, Remzi BK, et al. A case-series of 29 patients with lichen planopilaris: the Cleveland Clinic Foundation experience on evaluation, diagnosis, and treatment. J Am Acad Dermatol. 2007;57:47–53.
- Chieregato C, Zini A, Barba A, et al. Lichen planopilaris: report of 30 cases and review of the literature. Int J Dermatol. 2003;42:342–345.
- Kang H, Alzolibani AA, Otberg N, et al. Lichen planopilaris. Dermatol Ther. 2008;21:249–256.
- Lyakhovitsky A, Amichai B, Sizopoulou C, et al. A case series of 46 patients with lichen planopilaris: demographics, clinical evaluation, and treatment experience. J Dermatolog Treat. 2015;26:275–279.
- Matta M, Kibbi AG, Khattar J, et al. Lichen planopilaris: a clinicopathologic study. J Am Acad Dermatol. 1990;22:594–598.
- Mehregan DA, Van Hale HM, Muller SA. Lichen planopilaris: clinical and pathologic study of forty-five patients. J Am Acad Dermatol. 1992;27:935–942.
- Sperling LC. Scarring alopecia and the dermatopathologist. J Cutan Pathol. 2001;28:333–342.
- Tan E, Martinka M, Ball N, et al. Primary cicatricial alopecias: clinicopathology of 112 cases. J Am Acad Dermatol. 2004;50:25–32.
- Tandon YK, Somani N, Cevasco NC, et al. A histologic review of 27 patients with lichen planopilaris. J Am Acad Dermatol. 2008;59:91–98.
- Cho BK, Sah D, Chwalek J, et al. Efficacy and safety of mycophenolate mofetil for lichen planopilaris. J Am Acad Dermatol. 2010;62:393–397.
- Mirmirani P, Willey A, Price VH. Short course of oral cyclosporine in lichen planopilaris. J Am Acad Dermatol. 2003;49:667–671.
- Whiting DA. Cicatricial alopecia: clinico-pathological findings and treatment. Clin Dermatol. 2001;19:211–225.
- Donati A, Molina L, Doche I, et al. Facial papules in frontal fibrosing alopecia: evidence. Arch Dermatol. 2011;147:1424–1427.
- Inaloz HS, Chowdhury MM, Motley RJ. Lupus erythematosus/lichen planus overlap syndrome with scarring alopecia. J Eur Acad Dermatol Venereol. 2001;15:171–174.
- Kossard S. Postmenopausal frontal fibrosing alopecia. Scarring alopecia in a pattern distribution. Arch Dermatol. 1994;130:770–774.
- Moreno-Ramirez D, Camacho Martinez F. Frontal fibrosing alopecia: a survey in 16 patients. J Eur Acad Dermatol Venerol.. 2005;19:700–705.
- Samrao A, Chew AL, Price V. Frontal fibrosing alopecia: a clinical review of 36 patients. Br J Dermatol. 2010;163:1296–1300.
- Feldmann R, Harms M, Saurat JH. Postmenopausal frontal fibrosing alopecia. Hautarzt. 1996;47:533–536.
- MacDonald A, Clark C, Holmes S. Frontal fibrosing alopecia: a review of 60 cases. J Am Acad Dermatol. 2012;67:955–961.
- Vaisse V, Matard B, Assouly P, et al. [Postmenopausal frontal fibrosing alopecia: 20 cases]. Ann Dermatol Venereol. 2003;130:607–610.
- Graham-Little EG. Folliculitis decalvans et atrophicans. Br J Dermatol. 1915;27:183–185.
- Ghislain PD, Van Eeckhout P, Ghislain E. Lassueur-Graham Little-Piccardi syndrome: a 20-year follow-up. Dermatology. 2003;206:391–392. doi: 10.1159/000069966
- Soares VC, Mulinari-Brenner F, Souza TE. Lichen planopilaris epidemiology: a retrospective study of 80 cases. An Bras Dermatol. 2015;90:666–670.
- Lajevardi V, Ghodsi SZ, Goodarzi A, et al. Comparison of systemic mycophenolate mofetil with topical clobetasol in lichen planopilaris: a parallel-group, assessor- and analyst-blinded, randomized controlled trial. Am J Clin Dermatol. 2015;16:303–311.
- Racz E, Gho C, Moorman PW, et al. Treatment of frontal fibrosing alopecia and lichen planopilaris: a systematic review. J Eur Acad Dermatol Venereol. 2013;27:1461–1470.
- Chiang C, Sah D, Cho BK, et al. Hydroxychloroquine and lichen planopilaris: efficacy and introduction of Lichen Planopilaris Activity Index scoring system. J Am Acad Dermatol. 2010;62:387–392.
- Tosti A, Piraccini BM, Iorizzo M, et al. Frontal fibrosing alopecia in postmenopausal women. J Am Acad Dermatol. 2005;52:55–60.
- Esteban-Lucia L, Molina-Ruiz AM, Requena L. Update on frontal fibrosing alopecia. Actas Dermosifiliogr. 2017;108:293–304.
- Ranasinghe GC, Piliang MP, Bergfeld WF. Prevalence of hormonal and endocrine dysfunction in patients with lichen planopilaris (LPP): A retrospective data analysis of 168 patients. J Am Acad Dermatol. 2017;76:314–320.
- Aminorroaya A, Janghorbani M, Amini M, et al. The prevalence of thyroid dysfunction in an iodine-sufficient area in Iran. Arch Iran Med. 2009;12:262–270.
- Akbartabar Toori MP, Kiani FM, Sayehmiri FP, et al. Prevalence of hypercholesterolemia, high LDL, and low HDL in Iran: a systematic review and meta-analysis. Iran J Med Sci. 2018;43(5):449–465.
- Meinhard J, Stroux A, Lunnemann L, et al. Lichen planopilaris: Epidemiology and prevalence of subtypes - a retrospective analysis in 104 patients. J Dtsch Dermatol Ges. 2014;12:229–235.
- Vano-Galvan S, Molina-Ruiz AM, Serrano-Falcon C, et al. Frontal fibrosing alopecia: a multicenter review of 355 patients. J Am Acad Dermatol. 2014;70:670–678.
- Nic Dhonncha E, Foley CC, Markham T. The role of hydroxychloroquine in the treatment of lichen planopilaris: A retrospective case series and review. Dermatol Ther. 2017;30.
- Spencer LA, Hawryluk EB, English JC. 3rd Lichen planopilaris: retrospective study and stepwise therapeutic approach. Arch Dermatol. 2009;145:333–334.
- Tursen U, Api H, Kaya T, et al. Treatment of lichen planopilaris with mycophenolate mofetil. Dermatol Online J. 2004;10:24
- Naeini FF, Saber M, Asilian A, et al. Clinical efficacy and safety of methotrexate versus hydroxychloroquine in preventing lichen planopilaris progress: a randomized clinical trial. Int J Prev Med. 2017;8:37.
- Donovan JC. Finasteride-mediated hair regrowth and reversal of atrophy in a patient with frontal fibrosing alopecia. JAAD Case Rep. 2015;1:353–355.
- Holmes S, Ryan T, Young D, et al. Frontal Fibrosing Alopecia Severity Index (FFASI): a validated scoring system for assessing frontal fibrosing alopecia. Br J Dermatol. 2016;175:203–207.